Back to Trials
NCT04399941NARecruiting

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Boston Medical Center

Start Date

8/3/2021

Completion Date

9/1/2026

Summary

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Eligibility Criteria

Age Range: 18 years to 85 years

Inclusion Criteria: * ESRD (end stage renal disease) patients at BMC (Boston Medical Center) * Receiving hemodialysis * Has a dialysis access malfunction * Undergoing a diagnostic fistulogram for the dialysis access malfunction Exclusion Criteria: * None

Interventions

DIAGNOSTIC_TEST

Venography

DIAGNOSTIC_TEST

Intravascular ultrasound (IVUS)

OTHER

Image processing

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

End Stage Renal Disease

Locations

Boston Medical Center

Boston, Massachusetts 02118

United States